Compliance with 10 years oral hormonal replacement therapy

Maturitas

Volumn 41, Issue 2, 2002, Pages 81-86

  Eiken, Pia ^a,b   Kolthoff, Niels ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Compliance; Hormonal replacement therapy; Norethisterone acetate; Oestradiol

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO; TRISEQUENS;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; LONG TERM CARE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERVIEWS; LONGITUDINAL STUDIES; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; PROGESTINS;

EID: 0037176789     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00246-8     Document Type: Article

References (16)

1. Prevention of spinal osteoporosis in oophorectomised women
2. Long-term estrogen replacement therapy prevents bone loss and fractures
3. Fracture protection provided by long-term estrogen treatment
4. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - Results of the Danish Osteoporosis Prevention study
5. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
6. Magnitude of pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment
7. Effects of 10 year's hormone replacement therapy on bone mineral content in postmenopausal women
8. Compliance with long-term oral hormonal replacement therapy
9. Continuos treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation
10. Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women
11. On menstrual bleeding with hormone replacement therapy
12. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors
13. Postmenopausal hormone use following a 3-year randomized clinical trial
14. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention
15. Compliance of oral and transdermal oestrogen replacement therapy
16. Hormonal replacement regimens and bleeding